Purpose: To evaluate the contribution of ursodeoxycholic acid (UDCA) in the first 12 months after Roux-en-Y gastric bypass in the prevention of gallstone formation. Methods: A community-based clinical trial was conducted. A total of 137 patients were included in the study; 69 were treated with UDCA, starting 30 days after the surgery, at a dose of 150 mg twice daily (300 mg/day) over a period of 5 consecutive m...
Roux-en-Y gastric bypass is the second most widely performed surgical modality in the world for the treatment of obesity. In this technique, classic laparoscopic surgical retractors are usually rigid, require an additional incision for its installation, or handled by an assistant during the surgical procedure, and involve the risk of liver injury. The objective of this study was to evaluate and validate a techn...